Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma.

Liu R, Colby AH, Gilmore D, Schulz M, Zeng J, Padera RF, Shirihai O, Grinstaff MW, Colson YL.

Biomaterials. 2016 Sep;102:175-86. doi: 10.1016/j.biomaterials.2016.06.031. Epub 2016 Jun 23.

PMID:
27343465
2.

Advances in the management of peritoneal mesothelioma.

Raza A, Huang WC, Takabe K.

World J Gastroenterol. 2014 Sep 7;20(33):11700-12. doi: 10.3748/wjg.v20.i33.11700. Review.

3.

Effectiveness of early and aggressive administration of fresh frozen plasma to reduce massive blood transfusion during cytoreductive surgery.

Saxena A, Chua TC, Fransi S, Liauw W, Morris DL.

J Gastrointest Oncol. 2013 Mar;4(1):30-9. doi: 10.3978/j.issn.2078-6891.2012.046.

4.

Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.

Pinnix CC, Fontanilla HP, Hayes-Jordan A, Subbiah V, Bilton SD, Chang EL, Grosshans DR, McAleer MF, Sulman EP, Woo SY, Anderson P, Green HL, Mahajan A.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):317-26. doi: 10.1016/j.ijrobp.2011.06.1985. Epub 2011 Nov 19.

5.

Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Baratti D, Kusamura S, Laterza B, Balestra MR, Deraco M.

World J Gastrointest Oncol. 2010 Jan 15;2(1):36-43. doi: 10.4251/wjgo.v2.i1.36.

6.
7.

Supplemental Content

Support Center